ATCvet code QJ54
| ATC codes |
|---|
| J Antiinfectives for systemic use |
| J01 Antibacterials for systemic use |
| J02 Antimycotics for systemic use |
| J04 Antimycobacterials |
| J05 Antivirals for systemic use |
| Human only |
| J06 Immune sera and immunoglobulins |
| J07 Vaccines |
| ATCvet only |
| QJ51 Antibacterials for intramammary use |
| QJ54 Antimycobacterials for intramammary use |
|
|
ATCvet code QJ54 Antimycobacterials for intramammary use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System for veterinary medicinal products, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products for veterinary use.[1][2] Subgroup QJ54 is part of the anatomical group QJ Antiinfectives for systemic use.[3]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
QJ54A Drugs for mycobacterial infections
QJ54AB Antibiotics
- QJ54AB02 Rifampicin
- QJ54AB03 Rifamycin
References
- ↑ "The ATCvet classification system" (PDF). European Medicines Agency. Retrieved 1 February 2020.
- ↑ "ATCvet Code, ein Klassierungssystem für Tierarzneimittel" (in German). University of Zurich. Retrieved 1 February 2020.
- ↑ "ATCvet Index 2022: code QJ54". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.